Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

Completed

Conditions studied: Bone Density, Cancer

In brief

The hypothesis is that postmenopausal women who have received chemotherapy have a greater bone loss than the same age controls. The aim of this study is to obtain baseline bone mineral density (BMD) data on women with breast and gynecological cancers who have received chemotherapy. By comparing the Z scores of postmenopausal women who have received chemotherapy with age matched controls this hypothesis can be evaluated. Another goal of the study is to compare the T-score of a Heel Bone Density Scan to the T-score of the DXA Scan to see if there is a good correlation between peripheral and DXA scores.

Key facts

Study ID

NCT00603551

Run by

Medical University of South Carolina

People needed

106

Starts

2006-11-01

Expected to finish

2009-12-01

Last updated by the study team

2018-06-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Postmenopausal woman
• Diagnosed with breast or gynecological cancer
• Treated with chemotherapy

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.